Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-273.61%
operating margin TTM
-285.58%
revenue TTM
8.63 Million
revenue per share TTM
0.08$
valuation ratios | |
|---|---|
| pe ratio | -3.29 |
| peg ratio | -0.04 |
| price to book ratio | 2.45 |
| price to sales ratio | 9.00 |
| enterprise value multiple | -6.08 |
| price fair value | 2.45 |
profitability ratios | |
|---|---|
| gross profit margin | 100.0% |
| operating profit margin | -285.58% |
| pretax profit margin | -273.5% |
| net profit margin | -273.61% |
| return on assets | -34.23% |
| return on equity | -57.16% |
| return on capital employed | -48.71% |
liquidity ratios | |
|---|---|
| current ratio | 3.36 |
| quick ratio | 3.36 |
| cash ratio | 3.23 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 0.00 |
| cash conversion cycle | 0.00 |
| receivables turnover | 0.00 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.13 |
| debt equity ratio | 0.29 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.22 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -2.96 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.47 |
| cash per share | 1.01 |
| operating cash flow per share | -0.46 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -2.96 |
| short term coverage ratios | -10.16 |
| capital expenditure coverage ratio | -77.80 |
Frequently Asked Questions
When was the last time ProQR Therapeutics N.V. (NASDAQ:PRQR) reported earnings?
ProQR Therapeutics N.V. (PRQR) published its most recent earnings results on 06-11-2025.
What is ProQR Therapeutics N.V.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. ProQR Therapeutics N.V. (NASDAQ:PRQR)'s trailing twelve months ROE is -57.16%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. ProQR Therapeutics N.V. (PRQR) currently has a ROA of -34.23%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did PRQR's net profit margin stand at?
PRQR reported a profit margin of -273.61% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is PRQR's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.36 in the most recent quarter. The quick ratio stood at 3.36, with a Debt/Eq ratio of 0.29.